These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G. Br J Psychiatry; 1987 Feb; 150():164-8. PubMed ID: 3307976 [Abstract] [Full Text] [Related]
23. [Double-blind study of tiapride and placebo in patients with subcontinuous essential headache]. Cerbo R, Casacchia M, Boni B, Corona R, Papola S, de Lena C. Riv Neurol; 1982 Feb; 52(1):51-64. PubMed ID: 7046024 [Abstract] [Full Text] [Related]
31. [Clinical trial of tiapride in patients with dyskinesia (author's transl)]. Chouza C, Romero S, Lorenzo J, Camano JL, Fontana AP, Alterwain P, Cibils D, Gaudiano J, Feres S, Solana J. Sem Hop; 1982 Mar 25; 58(12):725-33. PubMed ID: 6283645 [Abstract] [Full Text] [Related]
32. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics. Csernansky JG, Prosser E, Kaplan J, Mahler E, Berger PA, Hollister LE. Biol Psychiatry; 1986 Jun 25; 21(7):632-42. PubMed ID: 2871874 [Abstract] [Full Text] [Related]
34. [Therapeutic measures in tardive dyskinesia]. Tegeler J, Wöller W. Fortschr Neurol Psychiatr; 1983 Jun 25; 51(6):203-26. PubMed ID: 6136457 [Abstract] [Full Text] [Related]
35. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM, Yu SC, Lin CC. J Clin Psychiatry; 2003 Nov 25; 64(11):1342-8. PubMed ID: 14658949 [Abstract] [Full Text] [Related]
36. [Treatment of dyskinesias with tiapride (author's transl)]. Kocher R, Hobi V. Sem Hop; 2003 Nov 25; 56(47-68):2033-4. PubMed ID: 6109379 [Abstract] [Full Text] [Related]